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ABSTRACT
Multitasking, or moonlighting, is the capability of
some proteins to execute two or more biologi-
cal functions. MultitaskProtDB-II is a database of
multifunctional proteins that has been updated. In
the previous version, the information contained
was: NCBI and UniProt accession numbers, canon-
ical and additional biological functions, organism,
monomeric/oligomeric states, PDB codes and bibli-
ographic references. In the present update, the num-
ber of entries has been increased from 288 to 694
moonlighting proteins. MultitaskProtDB-II is contin-
ually being curated and updated. The new database
also contains the following information: GO descrip-
tors for the canonical and moonlighting functions,
three-dimensional structure (for those proteins lack-
ing PDB structure, a model was made using Itasser
and Phyre), the involvement of the proteins in hu-
man diseases (78% of human moonlighting proteins)
and whether the protein is a target of a current drug
(48% of human moonlighting proteins). These num-
bers highlight the importance of these proteins for
the analysis and explanation of human diseases and
target-directed drug design. Moreover, 25% of the
proteins of the database are involved in virulence
of pathogenic microorganisms, largely in the mecha-
nism of adhesion to the host. This highlights their im-
portance for the mechanism of microorganism infec-
tion and vaccine design. MultitaskProtDB-II is avail-
able at http://wallace.uab.es/multitaskII.
INTRODUCTION
Multitasking, or moonlighting, refers to those proteins
presenting two or more functions performed by a single
polypeptide chain. The term ‘moonlighting’ was coined by
Constance Jeffery (1), whereas Joram Piatigorsky proposed
gene sharing (2). Multitasking proteins present alternative
functions, resulting from differences in cellular localization,
cell type, oligomeric state, concentration of cellular ligands,
substrates, cofactors, products or post-translational modifi-
cations. Although some findings suggest the involvement of
a protein in extra functions, for example, finding them in dif-
ferent cellular localizations or in amounts exceeding those
required for their canonical function, usually multitasking
proteins are experimentally revealed by serendipity. The ap-
pearance of a new function can become an advantage for the
cell or the organism because it reduces the number of pro-
teins to be synthesized, making its genome more compact
and coordinating cell activities better. In any case, these pro-
teins complicate the interpretation of knock-out/knock-in,
DNA array, metabolomic, systems biology, drug pharma-
cokinetic, pharmacodynamic and toxicity assays. In order
to facilitate the work of researchers interested in this field,
we decided to make our set of multitasking proteins freely
available in the form of a web database, MultitaskProtDB
(3). Additionally, two other databases are currently avail-
able: MoonProt (4) and MoonDB (5).
DATABASE IMPROVEMENTS
Information on multitasking proteins has been collected
from the literature through the NCBI PubMed server using
keywords like moonlighting/multitasking/multifunctional
protein and gene sharing. When necessary, some impor-
tant protein characteristics have been retrieved from the
UniProt Consortium (6). In order to identify which pro-
teins of our database are involved in human diseases, the
information present in the Online Mendelian Inheritance
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Table 1. Most frequent folds between moonlighting proteins in which the 3D structure is available
SCOPe ID FOLDS FREQUENCY
c1 TIM beta/alpha-barrel 9
c2 NAD(P)-binding Rossmann-fold domains 9
b1 Immunoglobulin-like beta-sandwich 6
c47 Thioredoxin fold 6
c37 P-loop containing nucleoside triphosphate hydrolases 5
c55 Ribonuclease H-like motif 4
c57 Molybdenum cofactor biosynthesis proteins 4
d144 Protein kinase-like (PK-like) 4
d54 Enolase N-terminal domain-like 4
i1 Ribosome and ribosomal fragments 4
a118 alpha-alpha superhelix 3
c8 The ‘swivelling’ beta/beta/alpha domain 3
d15 beta-Grasp (ubiquitin-like) 3
d162 LDH C-terminal domain-like 3
d58 Ferredoxin-like 3
a127 L-aspartase-like 2
a45 GST C-terminal domain-like 2
b26 SMAD/FHA domain 2
b29 Concanavalin A-like lectins/glucanases 2
b35 GroES-like 2
b42 beta-Trefoil 2
b69 7-bladed beta-propeller 2
b85 beta-clip 2
c23 Flavodoxin-like 2
c26 Adenine nucleotide alpha hydrolase-like 2
c42 Arginase/deacetylase 2
c58 Aminoacid dehydrogenase-like, N-terminal domain 2
c67 PLP-dependent transferase-like 2
c80 SIS domain 2
d2 Lysozyme-like 2
d41 alpha/beta-Hammerhead 2
d8 Urease, gamma-subunit 2
g37 beta-beta-alpha zinc fingers 2
b98 Zn aminopeptidase N-terminal domain 2
in Man (OMIM) (7) and Human Gene Mutation Database
(HGMD) (8) databases, have been carefully inspected.
Moreover, in order to check which proteins of our database
are a drug target, the Therapeutic Target Database (TTD)
(9) and theDrugBank database (10) have been scanned. The
three-dimensional (3D) structure of those proteins without
a previously-solved PDB structure has been modeled by ap-
plying the ITasser (11) and Phyre (12) servers. Bothmethods
use template-based tertiary structure modeling.
Using the SCOP code associated with the PDB struc-
ture with which the sequence of the moonlighting protein
aligned, a table of observedmain fold frequencies was made
(Table 1). In order to study any fold preference in our
database of moonlighting proteins, all proteins were aligned
with the astral95 database, and a protein subset was made
considering only those with <95% of identity (moon95).
With this strategy, we wished to prevent the abundance of
the same protein of close species and avoid over-represented
proteins because of the accumulation of the same protein
with multiple moonlighting functions. To test whether the
distribution of fold frequencies is similar to what we would
see if the moonlighting proteins had the same distribu-
tion of folds as that observed in the astral95 database, the
frequency distribution of subset moon95 was compared
with the distribution present in the proteins of the astral95
database. This was done using a G-test calculated through
a specific statistical R package (www.r-project.org). The P-
value provided by R was <2.2 × 10–16, which is below the
acceptance threshold of the null hypothesis. We could then
conclude that the distribution of frequencies in the struc-
tural classes of both subgroups of proteins is different.
USER INTERFACE
Upon opening the database web page (Figure 1), a large
table that contains 694 entries of multitasking proteins is
shown. Fifteen columns in the table give different infor-
mation regarding the main characteristics of each protein.
Alphabetically ordering is available by clicking on the ti-
tle of each column, and this allows to order, for example,
by organisms. From left to right, the following information
is shown: Column 1 is a clickable button to see the com-
plete record details. Column 2 is a clickable button to select
the entry. Column 3 (UniProt) shows the UniProt accession
number, which is linked to the corresponding database in-
formation. Column 4 (Protein Name) shows the name of
the protein. Column 5 (Canonical Function) contains a de-
tailed description of the canonical function of the protein.
Columns 6 and 8 (GO andGOMoon) display GO numbers
related to the canonical and moonlighting protein func-
tions, respectively. Column 7 (Moonlighting Function) con-
tains a detailed description of the moonlighting functions.
Column 9 (Organism) indicates the organism in which the
protein acts as a moonlighting protein according to the bib-
liography. Column 10 (Human Disease) indicates the asso-
ciated diseases in the case of human moonlighting proteins
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Figure 1. A screenshot of MultitaskProtDB-II web page. Currently, the database contains information of 694 multitasking proteins that can be easily
viewed with the search button and other display facilities.
that are linked to the OMIM database. Column 11 (Drugs)
indicates whether the protein is a known target of current
drugs and is linked to the DrugBank database information.
Column 12 (PDB) points to the PDB structure with which
the structure was modeled (sequence identity is shown as a
percentage), or to the experimentally solved PDB structure
of the protein entry (homology is 100). Column 13 (Models)
gives the 3D structure model with highest score according
to ITasser or Phyre servers. These models were obtained by
using the same sequence of the moonlighting protein and
they are highly reliable, as they were modeled starting from
high-homology templates. Even so, the reliability and cover-
agemight be low in some cases, particularly if they are based
on very remote homologs. Column 14 (Reference) provides
a link to the PubMed bibliographic reference. Some facili-
ties like display, print or search buttons are provided by the
web page. Moreover, an export process can be easily per-
formed to the whole database or to some selected entries.
The type of data file obtained through the export option
can be selected depending on the type of data file required
by the user (Excel, Word, CSV or XML). The database is
accessible at http://wallace.uab.es/multitaskII.
CONCLUSION
An important issue included in the present version of the
database is the relation between multitasking proteins and
human diseases. We have seen that 78% of the human
moonlighting proteins are involved in diseases. Further-
more, 48% of the human multifunctional proteins are tar-
gets of current drugs. According to UniProt, the number
of human proteins with a reviewed status is 26 199, and
13.74% of them are related to human diseases (see cross-
reference betweenUniProt andOMIMatwww.uniprot.org/
help/involvement in disease). Thus, a percentage as high as
the previously mentioned 78% indicates that moonlighting
proteins are prone to be involved in human diseases, prob-
ably because of the two or more exhibited molecular func-
tions. This is the case of fumarate hydratase, in which each
molecular function is related to a different disease (fumarate
deficiency and leiomiomatosis). Amore unexpected result is
the 48% of moonlighting proteins that are targets of current
drugs (9,10), since only 9.8% of the human proteins present
in UniProt are specified as drug targets. Moreover, targets
of current drugs represent only successful cases, because not
all the theoretically druggable human genome (5000–10 000
proteins, according to Drews, (13)) can be targetable. Still,
a drug acting on a moonlighting protein can trigger more
complicated toxic side-effects. Another interesting issue is
that 25% of the database entries correspond to proteins in-
volved in pathogenic microorganisms’ virulence, mostly in
the mechanism of host adhesion and colonization through
interaction with plasminogen or extracellular matrix com-
ponents. From the reverse vaccinology point of view, it is
a very important fact. Several authors (14,15) have previ-
ously reviewed the involvement of moonlighting proteins in
pathogen virulence.
The percentages described above highlight the interest of
moonlighting proteins for gaining insight into the molecu-
lar basis of genetic-based diseases, the rational drug-design
upon target identification, and the infection mechanism of
pathogens and vaccine design. Databases such as Multi-
taskProtDB (3), MoonProt (4) and MoonDB (5) can be
used as a source of data to create models or validate hy-
potheses about these proteins. Our database contains close
to 700 experimentally demonstrated moonlighting proteins,
withmuch information related to each one, and is a valuable
resource for this growing class of proteins.
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